Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents
Open accessThe DOI matches its Crossref record; 75 of the 78 references it cites were found in a registry or an index; 36 of the 43 sources its claims cite were checked for support.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS. In adolescence, the cornerstones of PCOS treatment are lifestyle and dietary interventions. In particular, the quality and quantity of carbohydrates introduced with the diet play a crucial role in the benefits of diet on PCOS. Recently, the ketogenic diet (KD) has attracted significant interest for the treatment of IR and for the control of carbohydrate metabolism, which has proven to be beneficial for several dysmetabolic conditions, including PCOS. The goal of the KD is to induce a fasting-like metabolism with production of chetonic bodies. Ketosis is a good regulator of calorie intake and mimics the starvation effect in the body, leading to body weight control and consequent metabolism. Additionally, during ketogenesis, insulin receptor sensitivity is also promoted. We proposed a broad overview of the available literature regarding KD indications and considered its metabolic benefits useful for improving PCOS management. The reported data support that a low-calorie ketogenic diet (LCKD) plays a positive role as a regulator of control weight, IR, glucose and lipid homeostasis and hormonal profile. Unfortunately, the evidence concerning the benefits of the very LCKD in adolescents with PCOS and excessive body weight is still numerically scarce. Further studies are necessary to understand whether these effects are due to weight loss or to the nutritional characteristics of this diet. Considering the long-term consequences of PCOS, it is crucial to detect the prospects of nutritional interventions to protect fertility, starting in adolescence.
Overview
CoChat Summary
## TL;DR
This is a narrative review arguing that low-calorie ketogenic diets may help manage polycystic ovary syndrome (PCOS), including in adolescents, by improving weight, insulin resistance, glucose/lipid homeostasis, and hormonal profiles. The authors conclude that adolescent-specific evidence is still scarce and that more studies are needed to separate the effects of ketosis from those of weight loss.
## Key findings
- The review cites evidence that in PCOS, low-carbohydrate dietary patterns can improve outcomes: a 2020 meta-analysis found a greater reduction in insulin resistance with low-carbohydrate than high-carbohydrate diets.
- In a randomized controlled trial of 72 overweight women with PCOS aged 16–45 years, a 12-week Mediterranean diet plus low-carbohydrate model improved anthropometric and endocrine parameters.
- A pilot study of 11 women with PCOS following a low-calorie ketogenic diet for 24 weeks reported that the 5 women who completed the study had significant reductions in body weight, free testosterone, LH/FSH ratio, fasting insulin, and symptoms; 2 conceived after 4 weeks.
- Across the studies discussed, the authors report short-term improvements in weight and fat mass loss, insulin resistance, glucose and lipid homeostasis, androgen levels, LH/FSH ratio, and SHBG.
## Methods
- Narrative review, described as a non-systematic summation and analysis of the literature on low-calorie ketogenic diets in PCOS, with a focus on adolescents.
- Searched MEDLINE/PubMed, Scopus, and Web of Science for the last 15 years, limited to English-language human studies; excluded in vitro, animal, elderly, epilepsy, and malnutrition studies.
- Screening flow: 201 papers identified, 69 titles/abstracts assessed, 41 full texts reviewed; disagreements were resolved by a fourth author.
## Limitations
- The paper explicitly states that evidence for the benefits of VLCKD in adolescents with PCOS and excessive body weight is “numerically scarce” and that clinical trials in adolescents are lacking.
- The authors state that further studies are needed to determine whether observed effects are due to weight loss or to the diet’s nutritional characteristics.
- Evident from the text: because this is a narrative, non-systematic review, the paper does not present a pooled effect estimate or a formal risk-of-bias assessment.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
24 Valid · 0 Not valid · 4 Not checked · 4 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Additionally, during ketogenesis, insulin receptor sensitivity is also promoted.”
- Also stated in: § 1. Introduction · plain
“During ketogenesis, insulin receptor sensitivity is also promoted; therefore, KD can modulate insulin fluctuation and secretion which are also caused by decreased carbohydrate intake, ultimately leading to improved insulin sensitivity [8,9,10].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > Abstract
What the sources say
- Partly supportedcites [8] Zhou, C., Wang, M., Liang, J., He, G., and Chen, N. (2022). Ketogenic Diet Benefits to Weight Loss, Glycemic Control, and Lipid Profiles in Overweight Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trails. Int. J. Environ. Res. Public. Health, 19. sourceExperimental — accuracy not yet measured
The Discussion (section 4; page not provided) says diet-induced mild ketosis might improve peripheral insulin sensitivity, which supports the general idea but is more tentative than the claim. It does not establish increased insulin receptor sensitivity specifically. The Results (section 3.5; page not provided) report no significant difference in HOMA-IR between diet groups. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [9] Cox, 2019, Ketogenic Diets Potentially Reverse Type II Diabetes and Ameliorate Clinical Depression: A Case Study, Diabetes Metab. Syndr. source
- Partly supportedcites [10] Goday, 2016, Short-Term Safety, Tolerability and Efficacy of a Very Low-Calorie-Ketogenic Diet Interventional Weight Loss Program versus Hypocaloric Diet in Patients with Type 2 Diabetes Mellitus, Nutr. Diabetes sourceExperimental — accuracy not yet measured
The Results (Diet-induced changes in efficacy parameters; page unavailable) report a lower HOMA-IR in the very-low-calorie ketogenic diet group than in the comparison group, and the Discussion interprets this as improved insulin sensitivity. The paper does not measure insulin receptor sensitivity or establish that ketogenesis caused the improvement; the Discussion says the study cannot separate the effects of weight loss from carbohydrate restriction. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In patients with excessive weight, achievable goals, such as 5% to 10% weight loss within six months, led to significant clinical improvements [2].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 5. Ketogenic Diet and Polycystic Ovary Syndrome
What the sources say
- Partly supportedcites [2] Teede, 2018, Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, Fertil. Steril. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) prioritizes lifestyle intervention to prevent or manage excess weight in people with PCOS. Our copy does not state a goal of 5%–10% weight loss within six months or report that achieving it led to significant clinical improvements; those specifics are not supported. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The Mediterranean diet (MD) is a dietary pattern rich in complex carbohydrates and fiber, and high in monounsaturated fat, that is closely associated with an improvement in low-grade chronic inflammation, IR, and hormonal derangements in PCOS [4].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 1. Introduction
What the sources say
- Partly supportedcites [4] Calcaterra, V., Verduci, E., Cena, H., Magenes, V.C., Todisco, C.F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., and Di Profio, E. (2021). Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients, 13. sourceExperimental — accuracy not yet measured
Section 6.3 associates the Mediterranean diet with improved insulin resistance in people with PCOS and excess body weight, and with reduced inflammation. It does not directly attribute improvement in hormonal derangements to the Mediterranean diet; its discussion of ovulatory cycles and androgen levels concerns low-glycemic-index diets more generally. Page numbers are unavailable in our copy. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This is also supported by the randomized controlled clinical trial conducted by Mei et al. in 2022 on a sample of 72 overweight women with PCOS (aged between 16 and 45), who followed a MD combined with a low-carbohydrate (LC) dietary model for 12 weeks, observing an improvement in anthropometric and endocrine parameters [65,66].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > 5. Ketogenic Diet and Polycystic Ovary Syndrome
What the sources say
- Partly supportedcites [65] Mei, 2022, Mediterranean Diet Combined With a Low-Carbohydrate Dietary Pattern in the Treatment of Overweight Polycystic Ovary Syndrome Patients, Front. Nutr. sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Could not verifycites [66] Paoli, 2013, Beyond Weight Loss: A Review of the Therapeutic Uses of Very-Low-Carbohydrate (Ketogenic) Diets, Eur. J. Clin. Nutr. sourceExperimental — accuracy not yet measured
The ‘Emerging evidence’ section discusses only preliminary evidence for very-low-carbohydrate ketogenic diets in PCOS; it does not describe the trial in the claim. Searches for Mei et al., the 72 participants, the 12-week Mediterranean–low-carbohydrate diet, and its outcomes found no passage in our copy addressing that trial. Page numbers were unavailable. (LLM, conf=0.78)
plainstates a causen = 72- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Hyperandrogenism, hyperinsulinism and insulin resistance (IR) are the main drivers of clinical, metabolic and reproductive phenotypes of PCOS.”
- Also stated in: § 1. Introduction · hedged
“The pathogenesis of PCOS remains not fully elucidated, and it is thought to be led by both exogenous and endogenous factors, with hyperandrogenism, hyperinsulinism and insulin resistance (IR) being the main drivers of clinical, metabolic and reproductive phenotypes [3].”
§ Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents > Abstract
What the sources say
- Partly supportedcites [3] Sadeghi, H.M., Adeli, I., Calina, D., Docea, A.O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., and Abdollahi, M. (2022). Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int. J. Mol. Sci., 23. sourceExperimental — accuracy not yet measured
Section 4.2 describes how insulin resistance, hyperinsulinemia and hyperandrogenism contribute to metabolic changes and disrupted follicle growth and ovulation. But the Introduction says PCOS has an incompletely understood, multifactorial etiology; the review does not establish these three as the main drivers of all clinical, metabolic and reproductive phenotypes. Page numbers are unavailable in our copy. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. Introduction · hedged
12 more claims · 9 with their cited sources checked
Create a free account to see all 32 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 13
- Probably not a substantial claim. 4
- The quote only partly states this claim. 1
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., & the International PCOS Network (2018) · Clinical Endocrinology · doi:10.1111/cen.13795 · Cited by 1,823
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., Andersen, M., Azziz, R., et al. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.05.004 · Cited by 1,325
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · cited 2×
“It is important to underline that cut-off values were lower than those applied to adult populations, and that the clinical hyperandrogenism score was lower in PCOS adolescents than in adults, according to what has been previously reported in the literature regarding the longer time needed for the pilosebaceous glands…”
BackgroundResultBeyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets
Paoli, A., Rubini, A., Volek, J. S., & Grimaldi, K. A. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.116 · Cited by 885
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676 · cited 1×
“In the first phase, patients follow a VLCKD (around 600 and 800 kcal/day) or a LCKD (>800 kcal/day and <total energy expenditure) (50); the latter is preferred to meet needs and avoid deficiencies in adolescents with PCOS [56,59].”
BackgroundHeritability of polycystic ovary syndrome in a Dutch twin-family study
Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1494 · Cited by 647 · cited 1×
“genes were involved in PCOS phenotype traits, such as obesity, insulin resistance, impaired ovulatory function, gonadotropin level regulation and infertility [17].”
BackgroundSanchez-Garrido, M. A., & Tena-Sempere, M. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.001 · Cited by 557
Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.
Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525 · cited 2×
“It is difficult to completely distinguish insulin resistance from hyperandrogenism in PCOS as they usually accompany each other [28].”
BackgroundPolycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445 · cited 2×
“The pathogenesis of PCOS remains not fully elucidated, and it is thought to be led by both exogenous and endogenous factors, with hyperandrogenism, hyperinsulinism and insulin resistance (IR) being the main drivers of clinical, metabolic and reproductive phenotypes [3].”
BackgroundCharacteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
Glueck, C. J., & Goldenberg, N. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.002 · Cited by 442 · cited 1×
“Obesity is seen in around 50% of PCOS patients, and significant differences have been identified according to ethnicity [27].”
BackgroundHealthy Effects of Plant Polyphenols: Molecular Mechanisms
Leri, M., Scuto, M., Ontario, M. L., Calabrese, V., Calabrese, E. J., Bucciantini, M., & Stefani, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041250 · Cited by 435 · cited 1×
“Polyphenols have shown efficacy in reducing inflammatory response and insulin secretion in PCOS [48,49].”
BackgroundTata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434 · cited 1×
“Although further studies are needed to assess the effect on humans, higher serum levels of dehydroepiandrosterone (DHEAS) and testosterone in the first years after menarche have been found in daughters of PCOS women than in controls in several studies [21,22].”
ResultPrenatal Androgen Exposure and Transgenerational Susceptibility to Polycystic Ovary Syndrome
Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H.-P., Zhao, Z., Massart, J., Ohlsson, C., Lindgren, E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0666-1 · Cited by 356 · cited 2×
“[20] demonstrated a five-fold increase in risk of developing PCOS in mice born from mothers with PCOS.”
BackgroundArmanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
Muscogiuri, G., El Ghoch, M., Colao, A., Hassapidou, M., Yumuk, V., Busetto, L., & Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) (2021) · Obesity Facts · doi:10.1159/000515381 · Cited by 289
The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
Bednarska, S., & Siejka, A. (2017) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/59380 · Cited by 284 · cited 1×
“Reports on the epidemiology of PCOS in adolescents are rare, and evaluation of its prevalence in adolescents may be difficult because of the high prevalence of paraphysiologic ovulatory dysfunction and of the common echographic finding of micropolycystic ovaries in this population; prevalence data depend on which diag…”
BackgroundCaprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283 · cited 7×
“); – Laboratory analysis (complete blood count, creatinine, uric acid, glucose, lipid profile, sodium, potassium, calcium, magnesium, inorganic phosphate, thyroid stimulating hormone (TSH), free- thyroxine (FT4), 25-Hydroxyvitamin D, complete urinalysis and microalbuminuria) [52].”
BackgroundInfluentialGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161356.esgl · Cited by 283
Effects of a Ketogenic Diet in Overweight Women with Polycystic Ovary Syndrome
Paoli, A., Mancin, L., Giacona, M. C., Bianco, A., & Caprio, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02277-0 · Cited by 281 · cited 1×
“Furthermore, improvement of ovulatory function led to pregnancy of two women after 4 weeks [67,68].”
BackgroundGregory, A. T., & Denniss, A. R. (2018) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2018.03.027 · Cited by 274 · cited 1×
“We performed a narrative review, presenting a non-systematic summation and analysis of the available literature on the topic of the application of low-calorie KDs in women with PCOS, focusing on adolescents [11].”
MethodSir-Petermann, T., Codner, E., Pérez, V., Echiburú, B., Maliqueo, M., Ladrón de Guevara, A., Preisler, J., Crisosto, N., Sánchez, F., Cassorla, F., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2836 · Cited by 260
Goday, A., Bellido, D., Sajoux, I., Crujeiras, A. B., Burguera, B., García-Luna, P. P., Oleaga, A., Moreno, B., & Casanueva, F. F. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.36 · Cited by 258
Luukkonen, P. K., Dufour, S., Lyu, K., Zhang, X.-M., Hakkarainen, A., Lehtimäki, T. E., Cline, G. W., Petersen, K. F., Shulman, G. I., & Yki-Järvinen, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922344117 · Cited by 249 · cited 2×
“Furthermore, the KD has been shown to lead to the reduction of hyperinsulinemia and the improvement of insulin sensitivity in patients with type 2 diabetes [56]; the improvement of patients suffering from non-alcoholic fatty liver disease (NAFLD) is instead determined by the reduction of insulin resistance due to the…”
BackgroundThe Effects of a Low-Carbohydrate, Ketogenic Diet on the Polycystic Ovary Syndrome: A Pilot Study
Mavropoulos, J. C., Yancy, W. S., Hepburn, J., & Westman, E. C. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-35 · Cited by 226
Govind, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.38 · Cited by 220 · cited 1×
“Epigenetic mechanisms have also been proposed as potential parts of the pathogenetic process; several animal models have shown higher incidence of PCOS following antenatal (as well as early postnatal period) androgen exposure [19].”
BackgroundOptimal Diet Strategies for Weight Loss and Weight Loss Maintenance
Kim, J. Y. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20065 · Cited by 193 · cited 1×
“These products include soups, smoothies and bars, but also ready meals with controlled portions; these foods are therefore essential in controlling the daily caloric intake [58].”
BackgroundCalcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183 · cited 7×
“Among the interventions for the treatment of PCOS that have been shown to have a positive impact on cardiometabolic health, decrease in androgen levels and menstrual irregularity, the modification of lifestyle is of particular importance, including physical activity, diet, regular sleep and weight loss when needed [4].”
BackgroundInfluentialSelf-citationAdvantages and Disadvantages of the Ketogenic Diet: A Review Article
Batch, J. T., Lamsal, S. P., Adkins, M., Sultan, S., & Ramirez, M. N. (2020) · Cureus · doi:10.7759/cureus.9639 · Cited by 181 · cited 4×
“This phase usually lasts from 8 to 12 weeks, depending on the individual and the agreed weight loss [56].”
BackgroundInfluentialThe Management of Very Low-Calorie Ketogenic Diet in Obesity Outpatient Clinic: A Practical Guide
Muscogiuri, G., Barrea, L., Laudisio, D., Pugliese, G., Salzano, C., Savastano, S., & Colao, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2104-z · Cited by 180 · cited 1×
“When the KD is also low in energy, rapid weight loss and improvement of the metabolic profile have also been identified, mainly due to decreased insulin levels and increased glucagon levels, in addition to ketosis [54].”
BackgroundBarrea, L., Marzullo, P., Muscogiuri, G., Di Somma, C., Scacchi, M., Orio, F., Aimaretti, G., Colao, A., & Savastano, S. (2018) · Nutrition Research Reviews · doi:10.1017/s0954422418000136 · Cited by 171
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa425 · Cited by 171 · cited 1×
“A 2020 meta-analysis concluded how important it is to provide professional dietary advice to all PCOS patients since diet is able to reduce IR and improve body composition [43].”
Hickey, M., Doherty, D. A., Atkinson, H., Sloboda, D. M., Franks, S., Norman, R. J., & Hart, R. (2011) · Human Reproduction · doi:10.1093/humrep/der102 · Cited by 170 · cited 1×
“Widely accepted criteria for diagnosing PCOS in the adolescent population are still lacking, but early recognition and intervention may bring significant benefits in terms of reducing the incidence of non-communicable diseases such as obesity and diabetes mellitus, other than reducing cardiovascular risk and increasin…”
BackgroundA New Approach to Polycystic Ovary Syndrome: The Gut Microbiota
Yurtdaş, G., & Akdevelioğlu, Y. (2020) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1657515 · Cited by 153
Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031780 · Cited by 151
Zhou, C., Wang, M., Liang, J., He, G., & Chen, N. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610429 · Cited by 151
Corbould, A. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.872 · Cited by 144 · cited 1×
“, androgens adversely influencing insulin action, has been also described [29].”
BackgroundMehrabani, H. H., Salehpour, S., Amiri, Z., Farahani, S. J., Meyer, B. J., & Tahbaz, F. (2012) · Journal of the American College of Nutrition · doi:10.1080/07315724.2012.10720017 · Cited by 141
A Review of Ketogenic Diet and Lifestyle.
McGaugh, E., & Barthel, B. (2022) · PubMed Central · Cited by 127
Borruel, S., Fernández-Durán, E., Alpañés, M., Martí, D., Álvarez-Blasco, F., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3698 · Cited by 122
Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS
Gower, B. A., Chandler‐Laney, P. C., Ovalle, F., Goree, L. L., Azziz, R., Desmond, R. A., Granger, W. M., Goss, A. M., & Bates, G. W. (2013) · Clinical Endocrinology · doi:10.1111/cen.12175 · Cited by 108 · cited 2×
“after a modest reduction in dietary carbohydrate intake [61,62].”
BackgroundDi Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 108
Tay, C. T., Hart, R. J., Hickey, M., Moran, L. J., Earnest, A., Doherty, D. A., Teede, H. J., & Joham, A. E. (2020) · BMC Medicine · doi:10.1186/s12916-020-01861-x · Cited by 97 · cited 1×
“A recent systematic review and meta-analysis that involved almost 150,000 adolescent girls around the globe stated that the prevalence of PCOS may be around 11% according to the Rotterdam criteria, with a higher prevalence in Middle-Eastern and South American women and lower prevalence in Asian populations [13].”
BackgroundAdolescent PCOS: a postpubertal central obesity syndrome
Ibáñez, L., & de Zegher, F. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.02.006 · Cited by 97
Calcaterra, V., Regalbuto, C., Porri, D., Pelizzo, G., Mazzon, E., Vinci, F., Zuccotti, G., Fabiano, V., & Cena, H. (2020) · Biomolecules · doi:10.3390/biom10091324 · Cited by 88
Self-citationDietary Interventions: A Promising Treatment for Polycystic Ovary Syndrome
Che, X., Chen, Z., Liu, M., & Mo, Z. (2021) · Annals of Nutrition and Metabolism · doi:10.1159/000519302 · Cited by 87 · cited 1×
“It has long been established that the Mediterranean diet (MD) has important anti-inflammatory and antioxidant properties because of the adequate intake of fibers, unsaturated fats and vitamins and bioactive compounds [47].”
BackgroundSteegers-Theunissen, R. P. M., Wiegel, R. E., Jansen, P. W., Laven, J. S. E., & Sinclair, K. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218211 · Cited by 82 · cited 1×
“PCOS is often associated with psychosocial problems such as anxiety disorder, depression and eating disorders, particularly binge-eating and bulimia nervosa; some authors have hypothesized that PCOS may be induced by epigenetic mechanisms triggered by dietary imbalance in early adolescence [34].”
BackgroundAndrogen Excess in Pancreatic β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes
Navarro, G., Allard, C., Morford, J. J., Xu, W., Liu, S., Molinas, A. J. R., Butcher, S. M., Fine, N. H. F., Blandino-Rosano, M., Sure, V. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98607 · Cited by 80
Effects of Mixed of a Ketogenic Diet in Overweight and Obese Women with Polycystic Ovary Syndrome
Cincione, R. I., Losavio, F., Ciolli, F., Valenzano, A., Cibelli, G., Messina, G., & Polito, R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312490 · Cited by 77
Mei, S., Ding, J., Wang, K., Ni, Z., & Yu, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.876620 · Cited by 75 · cited 2×
“This could be explained by the fact that excessive carbohydrate (CHO) intake leads to constant low-grade inflammation associated with IR and hyperandrogenism, resulting in increased production of reactive oxygen species (ROS), oxidative stress and inflammation [65].”
BackgroundMethodGünalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
Marzouk, T. M., & Sayed Ahmed, W. A. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.01.002 · Cited by 73 · cited 1×
“demonstrated that dietary weight loss in adolescent women with a body mass index (BMI) greater than 30 kg/m2 led to significant improvement in menstrual regularity, hirsutism score and anthropometric parameters [60].”
BackgroundDietary support in insulin resistance: An overview of current scientific reports
Gołąbek, K. D., & Regulska-Ilow, B. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/109976 · Cited by 62
Ketogenic Diet as Medical Prescription in Women with Polycystic Ovary Syndrome (PCOS)
Barrea, L., Verde, L., Camajani, E., Cernea, S., Frias-Toral, E., Lamabadusuriya, D., Ceriani, F., Savastano, S., Colao, A., & Muscogiuri, G. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00456-1 · Cited by 62
Ladson, G., Dodson, W. C., Sweet, S. D., Archibong, A. E., Kunselman, A. R., Demers, L. M., Lee, P. A., Williams, N. I., Coney, P., & Legro, R. S. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.05.048 · Cited by 56 · cited 1×
“Despite favorable clinical effects both on hyperandrogenism features and menstrual cycle regularity, metformin showed no superiority when compared to lifestyle intervention alone or combined oral contraceptives [38,39].”
BackgroundDoes the Ketogenic Diet Improve the Quality of Ovarian Function in Obese Women?
Magagnini, M. C., Condorelli, R. A., Cimino, L., Cannarella, R., Aversa, A., Calogero, A. E., & La Vignera, S. (2022) · Nutrients · doi:10.3390/nu14194147 · Cited by 52 · cited 1×
“[70] have shown that the use of different protocols (in terms of duration and composition) of KD in a population aged, respectively, 16–45, >18 and 18–45 of overweight and obese women diagnosed with PCOS led to statistically significant results on endocrine and metabolic parameters.”
ResultButt, M. S., Saleem, J., Zakar, R., Aiman, S., Khan, M. Z., & Fischer, F. (2023) · BMC Public Health · doi:10.1186/s12889-023-15730-8 · Cited by 52 · cited 2×
“Further studies are necessary to understand whether these effects are due to weight loss or to the nutritional characteristics of this diet [42].”
BackgroundPolycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
Genazzani, A. D., & Genazzani, A. R. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.71 · Cited by 48 · cited 1×
“IR and subsequent compensatory hyperinsulinemia is also thought to play a central role in PCOS reproductive and metabolic manifestations, with a prevalence of 70–80% in overweight women and of 30% in lean women [25].”
BackgroundReproductive and metabolic features during puberty in sons of women with polycystic ovary syndrome
Crisosto, N., Echiburú, B., Maliqueo, M. A., Luchsinger, M., Rojas, P., Recabarren, S. E., & Sir‐Petermann, T. (2017) · Endocrine Connections · doi:10.1530/ec-17-0218 · Cited by 46 · cited 1×
“Due to this pathogenetic hypothesis, a new acronym was recently proposed: “Postpubertal Central Adiposity Syndrome” [23].”
BackgroundPorchia, L. M., Hernandez-Garcia, S. C., Gonzalez-Mejia, M. E., & López-Bayghen, E. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.03.010 · Cited by 45 · cited 2×
“showed that both a balanced hypocaloric diet and a high-protein, low-glycemic-load, hypocaloric diet led to significant weight loss and reduction in androgen levels, and the second type of diet led also to improvement in insulin sensitivity [62,63].”
BackgroundCox, N., Gibas, S., Salisbury, M., Gomer, J., & Gibas, K. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.055 · Cited by 44
Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
Reiser, E., Lanbach, J., Böttcher, B., & Tóth, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010067 · Cited by 41 · cited 1×
“Metformin is widely used off-label in patients with metabolic impairments, given its insulin-sensitizing activity through inhibition of hepatic gluconeogenesis and increase in peripheral tissues’ glucose uptake [36,37].”
BackgroundPandurevic, S., Mancini, I., Mitselman, D., Magagnoli, M., Teglia, R., Fazzeri, R., Dionese, P., Cecchetti, C., Caprio, M., Moretti, C., et al. (2023) · Endocrine Connections · doi:10.1530/ec-22-0536 · Cited by 36
Metformin treatment of PCOS during adolescence and the reproductive period
Marca, A. L., Artenisio, A. C., Stabile, G., & Volpe, A. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.09.015 · Cited by 28
Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents
Khalifah, R. A. A., Flórez, I. D., Zoratti, M. J., Dennis, B. B., Thabane, L., & Bassilious, E. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa155 · Cited by 26
Weight Management in Adolescents with Polycystic Ovary Syndrome
Moore, J. M., Waldrop, S., & Cree‐Green, M. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00437-x · Cited by 23 · cited 1×
“The low-glycemic-index diet has also [44] shown a positive impact on inflammatory marker decreases and IR improvement, as also confirmed by others [45,46].”
BackgroundExploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects
Zhang, H., Butoyi, C., Yuan, G., & Jia, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110781 · Cited by 21 · cited 1×
“obesity, and several studies have described decreased abundance and variability in both lean and overweight PCOS patients, suggesting a possible new therapeutic frontier [30].”
BackgroundKiconco, S., Earnest, A., Enticott, J., Hart, R. J., Mori, T. A., Hickey, M., Teede, H. J., & Joham, A. E. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad055 · Cited by 19 · cited 1×
“It has been estimated that 25% of adolescents with PCOS have an affected mother, and several studies reported a higher incidence of PCOS in monozygotic twins than in dizygotic twins or siblings exposed to the same environment [16].”
BackgroundWu, L., Liu, Y., Huang, X., Lin, K., Liu, Y., Li, Z., Wei, T., Song, L., Hua, Y., & Wang, X. (2023) · Clinical Endocrinology · doi:10.1111/cen.14895 · Cited by 17 · cited 1×
“compared the metabolic effect of oral contraceptives and combination of oral contraceptives plus metformin in non-obese adult PCOS patients, and concluded that the combination of the two drugs achieved significant reduction of hyperinsulinemia, although the effect was mostly due to hepatic insulin clearance and not to…”
BackgroundDiVall, S. A. (2023) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001255 · Cited by 6 · cited 1×
“The low-glycemic-index diet has also [44] shown a positive impact on inflammatory marker decreases and IR improvement, as also confirmed by others [45,46].”
BackgroundAmin, M., & Gragnoli, C. (2023) · PubMed · doi:10.26355/eurrev_202304_32171 · Cited by 4 · cited 1×
“Other than PCOS predisposition itself, polycystic ovarian morphology is generally inherited in an autosomal dominant fashion [18].”
BackgroundDefinizione di dieta chetogena: creatività o confusione?
Frigerio, F., Poggiogalle, E., & Donini, L. M. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01178-2 · Cited by 3
Cited by
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
“…indicated an imbalance Indeed, IR was recently shown to have a prevalence of 70–80% in women with PCOS who are overweight and 30% in lean women [18,20]. speci fi c bacterial species, such as Bacteroidetes and Firmicutes, in women with PCOS, which can impact the production of short-chain fa tt…”
BackgroundInfluentialSelf-citationEffects of ketogenic diets on polycystic ovary syndrome: a systematic review and meta-analysis
Cannarella, R., Rubulotta, M., Leonardi, A., Crafa, A., Calvo, A., Barbagallo, F., Vignera, S. L., & Calogero, A. E. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01411-1 · Cited by 23
“These factors also increase cardiovascular risk [29, 32].”
Johnson, C., Garipoğlu, G., Jeanes, Y., Frontino, G., & Costabile, A. (2025) · Current Nutrition Reports · doi:10.1007/s13668-024-00601-4 · Cited by 27
Clemente‐Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Sepulveda, R. A. Y., Rubio-Zarapuz, A., Martín-Rodríguez, A., Navarro-Jiménez, E., & Tornero-Aguilera, J. F. (2025) · Metabolites · doi:10.3390/metabo15070453 · Cited by 21
Wu, J., & Jacobson-Dickman, E. E. (2025) · Nutrition · doi:10.1016/j.nut.2025.113021 · Cited by 6
Metadata
- Authors
- Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G.
- Affiliations
- University of Pavia (IT)
- Ospedale dei Bambini Vittore Buzzi (IT)
- University of Milan (IT)
- Corresponding author
- Cena, Hellas
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-08-15
- Volume
- 15
- Issue
- 16
- Pages
- 3582
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10459579
- OpenAlex
- W4385839940
- Semantic Scholar
- 19b1163708dd0b442d2f35c32d5476d26d88dfd9
- Cited by
- 27
- References
- 78
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 8
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Union-NextGenerationEU (PE00000003)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- polycystic ovary syndrome, ketogenic diet, adolescents, insulin resistance, weight loss, carbohydrate metabolism, insulin sensitivity, hyperinsulinism, hyperandrogenism, lipid homeostasis, glucose homeostasis, fertility preservation, dietary intervention
- MeSH terms
- Body Weight, Energy Intake, Female, Humans, Hyperinsulinism, Insulin Resistance, Polycystic Ovary Syndrome, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
